Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
1,064 total articles
Chubb trades like a high-quality insurer at a reasonable price: double-digit ROE, P/E near 12, and a 52-week range that still leaves room above current levels. I lay out a mid-term (45 trading days) swing trade to capture an 8% move toward $328 while limiting downside with a $292 stop. The thesis balances stable underwriting performance and balance…
FLEX LNG (FLNG) trades at about $26.53 and yields ~11.3% from consistent $0.75 quarterly distributions. With a market cap near $1.43B, a modest P/B and P/E, and steady charter-driven cash flow, the stock offers an asymmetric income-first trade. I outline an entry, stop, and target for a 180-trading-day hold and the key catalysts and risks to watch.
Warrior Met Coal (HCC) trades at elevated multiples but sits on a large cash cushion and low leverage. If Blue Creek meaningfully lowers unit costs and boosts production, the company can convert its cash cushion into positive free cash flow and justify a return toward its 52-week highs. This trade idea outlines an actionable long with entry, stop, …
UnitedHealth (UNH) is a structurally advantaged insurer and healthcare services platform that just got cheaper after a policy surprise and disappointing top-line guidance. Fundamentals still show strong free cash flow, a reasonable valuation and operating leverage through Optum. This trade buys the dip with a defined stop and a 180 trading-day targ…
Boston Beer is down materially from its 52-week high but still generates healthy free cash flow, carries no debt, and trades at a reasonable multiple versus its cash generation. This trade plan targets a recovery to near prior highs while protecting capital with a tight stop and staged profit-taking across a 180-day horizon.
AngloGold Ashanti has become the cleanest way to play the recent gold rally: production growth, record free cash flow, and strategic M&A have pushed the stock to a new 52-week high. The technicals show bullish momentum but also an overbought short-term reading. This trade idea buys strength with a disciplined stop at $98 and a mid-term target of $1…
Urban Outfitters (URBN) combines a debt-free balance sheet, $402.7M in free cash flow and accelerating brand performance into a tradeable long: entry $69.61, target $82.00, stop $62.00. Valuation is reasonable (P/E ~13, EV/EBITDA ~8.5) and the stock trades well below this cycle's highs, leaving room for a re-rate if top-line momentum and subscripti…
Meta surged after Q4 strength and looks set to extend gains as AI tailwinds roll through its ad and infrastructure businesses. Valuation is reasonable given free cash flow strength and low leverage. This trade plan targets $900 over the next 180 trading days with a strict stop at $640 to respect the technical picture and protect against macro-drive…
VEON offers an asymmetric risk-reward: Kyivstar’s operational wins (Starlink Direct-to-Cell scale, solar acquisition) and other regional growth initiatives justify a long trade at current levels given a P/E near 6 and a $3.73B market cap. Actionable plan included.
Willdan Group (WLDN) sits squarely in the grid-modernization theme: technical consulting for utilities plus civil engineering services. Strong free cash flow, low leverage, and bullish technicals argue for a tactical long. Valuation is rich, so position sizing and a tight stop are essential.
Hess Midstream combines recurring fee-based midstream cash flows with an equity yield north of 8% and valuation metrics that look compressed versus its cash generation. Given an improving technical backdrop and upcoming dividend pay dates, we see a pragmatic long trade with defined risk: enter at $36.00, target the prior 52-week high at $44.14, sto…
Sportradar is a market leader in sports data and betting technology with accelerating margins, a string of strategic deals (IMG ARENA, Bundesliga expansion), active buybacks and a current technical oversold setup. At a market cap of ~$5.8B and rich but justifiable growth expectations, I view SRAD as a long-term trade for investors willing to tolera…
AerCap (AER) looks attractively priced for 2026: market cap roughly $25.2B, a trailing P/E near 6.6, and a recovery from the 2025 low leaves room to run. We lay out an actionable long trade with entry, stop, and target, review the fundamentals that matter for lessors, and spell out the risks that would invalidate the thesis.
Hercules Capital (HTGC) offers an 8%-9% yield, a modest P/E near 11 and a P/B around 1.5. For income-seeking investors who can tolerate credit and rate volatility, HTGC presents a balanced long trade: collect a high dividend while holding for potential capital appreciation as credit performance and rate expectations normalize.
Tencent is set to benefit from Beijing's renewed emphasis on domestic tech services and a looser stance on high-end AI chip imports. At a $717B market cap and a P/E of ~23.5, Tencent offers a blend of growth (cloud, FinTech, games) and cash flow stability. We favor a long trade with a clear entry, stop and target tied to observable technical and po…
Chemours (CC) looks set to re-rate in 2026 as tight supply for high-purity hydrofluoroethers, steady demand for Opteon refrigerants, and improving technical momentum combine with a cheap starting valuation versus enterprise value. We present a long trade with entry at $15.10, stop at $13.00 and a $22.00 target over a 46-180 trading day time frame.
Cullinan Therapeutics (CGEM) is a clinical-stage oncology and immuno-immunology developer trading at roughly $700M market cap while sitting on a substantial cash reserve. With CLN-978 advancing toward clinical readouts, a positive zipalertinib trajectory and a reported cash runway into 2028, Cullinan offers an asymmetric long opportunity: the marke…
General Mills is trading like a broken consumer staples play despite healthy cash flow, a double-digit return on equity, and a 5%+ dividend yield. This trade idea lays out a swing trade to take advantage of excessive pessimism while keeping tight risk controls below recent support.
Exelixis (EXEL) is a profitable oncology company trading near $42.67 with solid free cash flow, low leverage and a pipeline catalyst in zanzalintinib. A favorable FDA outcome could push the stock toward the mid-$40s to $50s; the trade below balances upside with a clear stop and a mid-term time horizon tied to a likely near-term regulatory event.
QuantumScape has moved beyond lab headlines into real vehicle testing and pilot production. With a market cap near $6.0B and a string of OEM and materials partnerships, the risk/reward favors a disciplined long position that targets bet-the-technology upside while protecting capital against execution failure.
Intuitive Machines (LUNR) has run hard into my prior price target after closing the Lanteris acquisition and posting strong market momentum. Fundamentals haven't caught up to the rally: elevated price-to-sales (~13x), negative free cash flow, and persistent insider selling. This trade idea recommends a measured short/momentum-fade entry at $22.81 w…
Hims & Hers ($HIMS) is trading near recent lows with strong fundamental levers and a crowded short base. Valuation looks demanding on some metrics but the risk/reward is attractive for an aggressive, defined-risk long over the next 45 trading days. Entry, stop and target included.
Aurora (AUR) is trading like a story stock priced for huge autonomous-vehicle success while sitting on a modest cash runway and nascent commercial revenue. The company has moved from lab to paid operations in trucking; that operational progress plus AI tailwinds create a mid-term trade opportunity. This idea is aggressive: enter at $4.50, target $6…
Okta sits squarely at the intersection of identity and emergent enterprise AI agents. Identity is a prerequisite for secure agent actions; that makes Okta a natural beneficiary if customers adopt agentic workflows widely. Valuation already reflects a pullback from the 52-week high and a $1 billion buyback set to cushion share count. This trade targ…
Alico (ALCO) is a small-cap agricultural holding that is quietly pivoting from pure citrus production toward land management and real estate monetization. With a newly expanded $95M credit facility, a dedicated EVP of Real Estate, and management guidance for ~$20M in land sales this fiscal year, the stock looks positioned for a re-rating if managem…
